Delivery Order SPE2DB20D3111-SPE2DB26FA5SE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on September 25, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,965.60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Eliquis 2.5 mg tablets (60-count) at a firm fixed price of $3,931.20. This non-competitive delivery order, with an ultimate completion date of August 25, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The contract will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,556.10. This contract represents a firm fixed price delivery order under a non-set-aside competitive procurement and is scheduled for ultimate completion on August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a prescription...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This contract is a non-set-aside, competitively awarded delivery order with a firm fixed price ceiling value of $12,911.85 and an ultimate completion date of November 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging) with a ceiling value of $1,228.50. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $15,724.80 to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 2.5 mg tablets, with an ultimate completion date of September 4, 2025. This non-competitive delivery order represents a firm fixed price transaction and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.50 on September 3, 2025, for the supply of Eliquis 2.5 mg tablets (60-count package). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $10,243.60. This firm fixed-price delivery order, which is set to be completed by August 6, 2025, represents a single-award contract with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $55,353.92. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 20, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The work will be performed at the company's corporate office...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB26FA5SEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,743.50 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Eliquis, an anticoagulant medication, represents one of the many therapeutic categories available through this contract vehicle, which provides critical medical commodities including specialty medications, brand-name and generic drugs, and related supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/10/25 |